NLB Skladi, upravljanje premozenja, d.o.o.
Position in CTMX — CytomX Therapeutics, Inc.
CIK 2110897
Ljubljana, 2A
Position in CTMX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$468,750
-$53,471 QoQ
Shares Held
125,000
+12.5% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#70
of 178 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CTMX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NLB Skladi, upravljanje premozenja, d.o.o. holds $16,165,282 across 11 Biotechnology names. CTMX ranks #8 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
13,181 | $6,547,398 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,895 | $2,428,688 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
8,500 | $1,591,880 | |
| 4 | ARGX |
Argenx SE
|
1,700 | $1,577,209 | |
| 5 | LEGN |
Legend Biotech Corp
|
50,000 | $1,444,000 | |
| 6 | TLX |
Telix Pharmaceuticals Ltd
|
58,000 | $668,740 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
11,111 | $605,993 | |
| 8 | CTMX |
CytomX Therapeutics, Inc.
This page
|
125,000 | $468,750 |
All Filings in CTMX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $468,750 | 125,000 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $522,221 | 111,111 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $426,000 | 100,000 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||